Human Genome Epidemiology Literature Finder
Records 1 - 9 (of 9 Records) |
Query Trace: Arthritis and CYP2C9[original query] |
---|
Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients. European journal of clinical pharmacology 2008 Sep 64 (9): 871-6. Bohanec Grabar Petra, Rozman Blaz, Tomsic Matija, Suput Dasa, Logar Dusan, Dolzan Vi |
Clinical pharmacokinetics of ketoprofen enantiomers in wild type of Cyp 2c8 and Cyp 2c9 patients with rheumatoid arthritis. European journal of drug metabolism and pharmacokinetics 2011 Sep 36 (3): 167-73. G?ówka Franciszek, Kara?niewicz-?ada Marta, Grze?kowiak Edmund, Rogozinska Dominika, Romanowski Wojcie |
Effects of CYP2C9 genetic polymorphisms on the pharmacokinetics of celecoxib and its carboxylic acid metabolite. Archives of pharmacal research 2016 Nov . Kim Se-Hyung, Kim Do-Hoon, Byeon Ji-Yeong, Kim Young-Hoon, Kim Dong-Hyun, Lim Hye-Jin, Lee Choong-Min, Whang Sang Sup, Choi Chang-Ik, Bae Jung-Woo, Lee Yun Jeong, Jang Choon-Gon, Lee Seok-Yo |
Influence of CYP2C9 and COX-2 Genetic Polymorphisms on Clinical Efficacy of Non-Steroidal Anti-Inflammatory Drugs in Treatment of Ankylosing Spondylitis. Medical science monitor : international medical journal of experimental and clinical research 2017 Apr 23 1775-1782. Wang Yu, Yi Xiao-Dong, Lu Hai-L |
Steroid hormone-related polymorphisms associate with the development of bone erosions in rheumatoid arthritis and help to predict disease progression: Results from the REPAIR consortium. Scientific reports 2019 Oct 9 (1): 14812. Sánchez-Maldonado Jose M, Cáliz Rafael, Canet Luz, Horst Rob Ter, Bakker Olivier, den Broeder Alfons A, Martínez-Bueno Manuel, Canhão Helena, Rodríguez-Ramos Ana, Lupiañez Carmen B, Soto-Pino María José, García Antonio, Pérez-Pampin Eva, González-Utrilla Alfonso, Escudero Alejandro, Segura-Catena Juana, Netea-Maier Romana T, Ferrer Miguel Ángel, Collantes-Estevez Eduardo, López Nevot Miguel Ángel, Li Yang, Jurado Manuel, Fonseca João E, Netea Mihai G, Coenen Marieke J H, Sainz Ju |
Screening study for genetic polymorphisms affecting pharmacokinetics of talniflumate. Translational and clinical pharmacology 2020 2 25 (4): 166-172. Jin Li Hua, Kim Bo-Hyung, Lee Ji Hyun, Lee Kidong, Kwack KyuBum, Yim Sung-V |
Physiologically based pharmacokinetic (PBPK) modeling for prediction of celecoxib pharmacokinetics according to CYP2C9 genetic polymorphism. Archives of pharmacal research 2021 Jul 44 (7): 713-724. Kim Young-Hoon, Kang Pureum, Cho Chang-Keun, Jung Eui Hyun, Park Hye-Jeong, Lee Yun Jeong, Bae Jung-Woo, Jang Choon-Gon, Lee Seok-Yo |
Physiologically based pharmacokinetic (PBPK) modeling of meloxicam in different CYP2C9 genotypes. Archives of pharmacal research 2021 11 44 (12): 1076-1090. Cho Chang-Keun, Park Hye-Jung, Kang Pureum, Moon Sungmin, Lee Yun Jeong, Bae Jung-Woo, Jang Choon-Gon, Lee Seok-Yo |
Physiologically based pharmacokinetic (PBPK) modeling of piroxicam with regard to CYP2C9 genetic polymorphism. Archives of pharmacal research 2022 5 45 (5): 352-366. Cho Chang-Keun, Kang Pureum, Park Hye-Jung, Ko Eunvin, Mu Chou Yen, Lee Yun Jeong, Choi Chang-Ik, Kim Hyung Sik, Jang Choon-Gon, Bae Jung-Woo, Lee Seok-Yo |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: